STAT News published a Health Tech newsletter item titled “Three questions with Whoop’s new CMO” on July 28, 2026. The accessible portion of the web page contains the article headline, byline, newsletter framing, and site navigation, but the substantive interview content is gated as a STAT+ exclusive. The page explicitly invites readers to subscribe or log in to read the remainder of the story.
The visible materials identify the interview format — a three-question Q&A — and single out Whoop and its new chief medical officer (CMO) as the subject. Beyond that structural information, the public excerpt does not include the CMO’s name, the three questions, the responses, or any clinical or operational details from the interview.
From the excerpted content on the page we can confirm the following limited points from the source text itself:
The article’s headline frames the piece as a brief Q&A with Whoop’s new CMO. Bold specifics such as the CMO’s identity, background, or statements are not present in the excerpt.
The item sits within STAT’s Health Tech coverage and is presented as part of the Health Tech newsletter. The newsletter context indicates that the wider edition also covered topics such as company pledges to CMS and the broader availability of ChatGPT Health, but the Whoop Q&A itself is marked exclusive.
The article page contains the usual STAT site elements: navigation to related topics (FDA, research, rare disease), links to other Health Tech stories, imagery associated with the newsletter, and promotional copy encouraging subscription to STAT+ for full access.
Because the substantive interview text is paywalled, any details about the CMO’s clinical or product priorities, regulatory views, research plans, or quoted material are not available from the provided source and therefore are not reported here.
The excerpt shows the Whoop Q&A positioned among other Health Tech newsletter items and STAT+ exclusives. Adjacent teasers and links on the page reference a range of topics that the author covers, such as FDA regulation of AI, Medicare reimbursement for health tech, use of AI in clinical care, mental health chatbots, and consumer wearables. The visible stories and newsletter snippets on the page include items about CMS pledge categories and ChatGPT Health becoming generally available.
This placement signals editorial intent to treat the Whoop interview as part of an ongoing beat focused on health tech, wearables, and regulatory and payment developments that affect digital health companies. However, the paywall prevents extraction of any interview-specific claims or clinical assertions from the source material.
The article is attributed to Mario Aguilar, identified on the page as STAT’s Health Tech correspondent. The byline includes contact information and social links that appear in the accessible header: an email address and social handles. The page also carries STAT’s standard site navigation, category links, and promotional branding for STAT+ and related newsletters.
The visible publication date is July 28, 2026. The article is explicitly labeled as an exclusive for STAT+ subscribers, and the excerpt includes subscription callouts and pricing tiers (monthly and annual plans) as part of the paywall interface.
The accessible page makes clear that the full interview text is available only to STAT+ subscribers. The public excerpt contains two primary calls to action: prompts to log in for existing subscribers and links to subscribe for new readers. Pricing and plan options are visible in the excerpt as part of STAT’s subscription interface. The page also contains links to related STAT+ content and to the Health Tech newsletter signup.
Because the interview content itself is gated, this summary documents only what is visible in the provided source. Specifics that would normally appear in a Q&A — the CMO’s name, professional background, answers to the three interview questions, and any factual claims about Whoop’s products, clinical evidence, or regulatory strategy — were not reported in the accessible portion of the article and therefore are not included here.
If you need the substantive Q&A material from this STAT+ exclusive, the source indicates the required action is to sign in to a STAT+ account or purchase a STAT+ subscription to access the remainder of the story.